Company intelligence / Profile preview

Multiply Labs

San Francisco, California, United States

Ownership: Private
Employees: ~34
Development stage: Other

Overview

Multiply Labs provides robotic manufacturing platforms for pharmaceutical companies, reporting marked improvements: up to 74% reduction in manufacturing costs and up to 100x more patient doses per cleanroom space compared to manual manufacturing of individualized drugs. Notably, Multiply Labs has partnered with Kyverna Therapeutics (CAR-T pilot program) and GenScript (cell isolation phase automation for cell therapy). It does not itself conduct clinical trials or develop therapeutics.

Modalities: Cell therapyGene-modified cell therapyPersonalized medicines
Industry: Non-Drug Biotech

Partnerships

GenScript Biotech Corporation (automation of cell isolation in cell therapy)Kyverna Therapeutics (automated CAR-T manufacturing pilot for KYV-102)

Beyond the preview

Go deeper on Multiply Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiply Labs.

Explore the full profile